Integrated DNA Technologies reviews

Limited growth opportunities. Questionable business practices. Poor management. Restructures and layoffs every quarter. Frequent turnover in leadership. Aware but unwilling to address poor management.

company prioritizes profits over mission. executive leadership does not deeply understand the chemistry of synthetic oligo manufacturing- most hold MBAs, or engineering degrees. few have molecular biology degrees. since being acquired the company has not staffed executive positions internally leading to a top down cultural shift that has pushed away many veteran employees. career mobility is virtually none. there are several people in the engineering department who's title hasn't changed in > 10 years. they stayed because it is a stable and challenging place to work and historically had a great culture, but since being acquired, much of that has been lost.